SEC Form D filing

Lighthouse Pharmaceuticals, Inc., 2026-05-07

An SEC Form D private-offering notice from Novato, CA, a $15,206,800 filer-stated offering target in Biotech. Filed 2026-05-07. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Clinical stage biopharmaceutical company developing precision therapeutics, including LHP588, a gingipain inhibitor in Phase 2 trials for P. gingivalis positive Alzheimer's disease

Filed 2026-05-07Filed to raise $15,206,800First money in 2026-04-22Raised so far $15,206,800HQ (as filed) Novato, CASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified lighthousepharma.com↗Named in the filing 3 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source